Ar - androgen receptor Gene

Also Known as Tfm; Andr

Species: Rattus norvegicus

Gene Type: protein coding

Gene ID: 24208

About Ar

Primary_assembly X: 63,104,771-63,273,925 forward strand.mRatBN7.2:CM026994.1

This gene has 1 transcript (splice variant), 277 orthologues, 8 paralogues and is associated with 62 phenotypes. Biased expression in Adrenal (RPKM 352.8), Uterus (RPKM 74.9) and 7 other tissues.

Summary

Enables several functions, including androgen binding activity; Androgen Receptor binding activity; and nuclear receptor activity. Involved in several processes, including cellular response to hormone stimulus; mating; and regulation of transcription, DNA-templated. Located in several cellular components, including axon; dendrite; and nucleus. Used to study hypertension; osteoporosis; prostate adenocarcinoma; prostate cancer; and prostatic hypertrophy. Biomarker of acute kidney failure and androgen insensitivity syndrome. Human ortholog(s) of this gene implicated in several diseases, including attention deficit hyperactivity disorder; conduct disorder; disorder of sexual development (multiple); reproductive organ Cancer (multiple); and spinal muscular atrophy (multiple). Orthologous to human AR (Androgen Receptor). [provided by Alliance of Genome Resources, Apr 2022]

Ar Products (1)

mRNA	Protein	Name
NM_012502.2	NP_036634.2	androgen receptor

Gene Ontology

Molecular Function
Biological Process
Cellular Component

Molecular Function GO Annotation	Evidence	References	Source
enables androgen binding	IMP IMP: Inferred from mutant phenotype	2341409	RGD
enables chromatin binding	IDA IDA: Inferred from direct assay	3499428	RGD
enables nuclear androgen receptor binding	IPI IPI: Inferred from physical interaction	9710597	RGD
enables nuclear receptor activity	IDA IDA: Inferred from direct assay	2341409	RGD
enables protein binding	IPI IPI: Inferred from physical interaction	12350225	RGD
enables protein domain specific binding	IPI IPI: Inferred from physical interaction	17223690	RGD
enables ribonucleotide binding	IDA IDA: Inferred from direct assay	6193790	RGD
enables sequence-specific DNA binding	IDA IDA: Inferred from direct assay	10385402	RGD
enables signaling receptor binding	IPI IPI: Inferred from physical interaction	11875111	RGD

Biological Process GO Annotation	Evidence	References	Source
involved in androgen receptor signaling pathway	IMP IMP: Inferred from mutant phenotype	2341409	RGD
involved in cellular response to follicle-stimulating hormone stimulus	IEP IEP: Inferred from expression pattern	2502458	RGD
involved in cellular response to steroid hormone stimulus	IEP IEP: Inferred from expression pattern	2341409	RGD
involved in copulation	IMP IMP: Inferred from mutant phenotype	15178162	RGD
involved in drinking behavior	IMP IMP: Inferred from mutant phenotype	28776866	RGD
involved in liver regeneration	IEP IEP: Inferred from expression pattern	2598758	RGD
involved in locomotion	IMP IMP: Inferred from mutant phenotype	28776866	RGD
involved in male courtship behavior	IMP IMP: Inferred from mutant phenotype	15178162	RGD
involved in male sex differentiation	IMP IMP: Inferred from mutant phenotype	2341409	RGD
involved in negative regulation of DNA-templated transcription	IDA IDA: Inferred from direct assay	10385402	RGD
involved in positive regulation of DNA-templated transcription	IDA IDA: Inferred from direct assay	10385402	RGD
involved in positive regulation of hippocampal neuron apoptotic process	IMP IMP: Inferred from mutant phenotype	18289534	RGD
involved in positive regulation of locomotion	IMP IMP: Inferred from mutant phenotype	28776866	RGD
involved in positive regulation of penile erection	IMP IMP: Inferred from mutant phenotype	21315100	RGD
involved in prostate gland growth	IEP IEP: Inferred from expression pattern	3628973	RGD
involved in reproductive behavior	IDA IDA: Inferred from direct assay	20392832	RGD
involved in response to environmental enrichment	IMP IMP: Inferred from mutant phenotype	28776866	RGD
involved in response to estradiol	IEP IEP: Inferred from expression pattern	10913783	RGD
involved in response to ethanol	IDA IDA: Inferred from direct assay	3678734	RGD
involved in response to insulin	IEP IEP: Inferred from expression pattern	15596216	RGD
involved in response to muscle activity	IEP IEP: Inferred from expression pattern	16286851	RGD
involved in response to nicotine	IEP IEP: Inferred from expression pattern	27602328	RGD
involved in response to steroid hormone	IEP IEP: Inferred from expression pattern	2644508	RGD
involved in response to testosterone	IEP IEP: Inferred from expression pattern	10913783	RGD
involved in skeletal muscle hypertrophy	IMP IMP: Inferred from mutant phenotype	7957162	RGD
involved in spermatogenesis	IMP IMP: Inferred from mutant phenotype	15347734	RGD

Cellular Component GO Annotation	Evidence	References	Source
located in axon	IDA IDA: Inferred from direct assay	12865346	RGD
located in cytosol	IDA IDA: Inferred from direct assay	3678734	RGD
located in dendrite	IDA IDA: Inferred from direct assay	12865346	RGD
located in nuclear matrix	IDA IDA: Inferred from direct assay	6466649	RGD
located in nucleus	IDA IDA: Inferred from direct assay	3678734	RGD

EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

Ar Protein Structure

Androgen_recep

NR_DBD_AR

NR_LBD_AR

0
200
400
600
800
902 a.a.

Protein Preferred Names	Protein Names
androgen receptor	androgen receptor (Testicular feminization), same as Tfm dihydrotestosterone receptor nuclear receptor subfamily 3 group C member 4

Related Agents

Approval
Clinical Phase
Pre-clinical Phase

Approval

Bioactive Molecules (65)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-70002	Enzalutamide		99.97%	Unkown
HY-13715	Norepinephrine		99.61%	Unkown
HY-B0573B	Propranolol	Antagonist	99.91%	Yes
HY-B0573	Propranolol hydrochloride	Antagonist	99.95%	Yes
HY-N0378	D-Mannitol		99.93%	Yes
HY-Y1269	Ammonium chloride, AR, 99.5%	Inhibitor	99.69%	Yes
HY-111372	Finerenone	Antagonist	99.91%	Unkown
HY-10064	Ticagrelor	Antagonist	99.95%	Yes
HY-N0092	Inosine	Agonist	99.94%	Yes
HY-13715A	Norepinephrine hydrochloride		99.95%	Yes
HY-16985	Darolutamide	Antagonist	99.49%	Unkown
HY-14249	Bicalutamide		99.92%	Unkown
HY-16060	Apalutamide	Antagonist	99.94%	Unkown
HY-17627	Avacopan	Inhibitor	98.50%	Yes
HY-B1037	Salbutamol		99.96%	Yes
HY-13715B	Norepinephrine bitartrate monohydrate		99.96%	Unkown
HY-13613	Dutasteride		98.81%	Yes
HY-19638A	Cangrelor tetrasodium	Antagonist	99.96%	Unkown
HY-15746	Dobutamine hydrochloride	Agonist	99.60%	Yes
HY-17042	Cetirizine	Antagonist	99.79%	Yes
HY-10122	Silodosin	Antagonist	99.89%	Yes
HY-12798	Netarsudil	Inhibitor	99.94%	Unkown
HY-108449	Acoltremon	Agonist	99.13%	Unkown
HY-N0138	Theobromine	Inhibitor	99.55%	Unkown
HY-14300A	Vilanterol trifenatate	Agonist	99.82%	Unkown
HY-17497A	Acebutolol hydrochloride	Antagonist	99.70%	Unkown
HY-B0436	Salbutamol hemisulfate		98.0%	Yes
HY-12798B	Netarsudil hydrochloride	Inhibitor	99.90%	Unkown
HY-13715R	Norepinephrine (Standard)		99.97%	Unkown
HY-B0111	Drospirenone	Agonist	99.95%	Unkown
HY-17042A	Cetirizine dihydrochloride	Antagonist	99.58%	Yes
HY-14301	Olodaterol	Agonist	99.85%	Unkown
HY-B0659	Brimonidine	Agonist	99.98%	Yes
HY-13715C	Norepinephrine tartrate		99.96%	Unkown
HY-B0659A	Brimonidine tartrate	Agonist	99.68%	Yes
HY-15746A	Dobutamine	Agonist	98.75%	Yes
HY-B1114	Gliquidone	Inhibitor	99.93%	Unkown
HY-12798A	Netarsudil dimesylate		99.90%	Unkown
HY-14300	Vilanterol	Agonist	99.30%	Unkown
HY-B1486	Oxprenolol hydrochloride	Antagonist	99.86%	Unkown
HY-14301A	Olodaterol hydrochloride	Agonist	99.70%	Unkown
HY-B1276	Metaproterenol hemisulfate	Agonist	99.44%	Unkown
HY-70002B	Enzalutamide carboxylic acid		98.60%	Unkown
HY-A0295	(R)-Propranolol hydrochloride	Antagonist	99.32%	Unkown
HY-B1470	Azaperone	Antagonist	99.23%	Unkown
HY-B0004	Doxofylline		99.97%	Yes
HY-B0010D	Arformoterol tartrate	Agonist	99.63%	Unkown
HY-B1037R	Salbutamol (Standard)		99.91%	Unkown
HY-U00205	Dopexamine hydrochloride	Agonist	98.04%	Unkown
HY-B0010A	Arformoterol	Agonist	99.96%	Unkown
HY-B1016	Trapidil	Inhibitor	98.0%	Unkown
HY-17497	Acebutolol	Antagonist	99.70%	Unkown
HY-B0659S	Brimonidine-d4	Agonist	99.13%	Unkown
HY-B0484	Buflomedil hydrochloride	Antagonist	99.86%	Unkown
HY-15746B	Dobutamine tartrate	Agonist	/	Unkown
HY-19638	Cangrelor	Antagonist	/	Unkown
HY-13613R	Dutasteride (Standard)		/	Unkown
HY-B0484A	Buflomedil	Antagonist	/	Unkown
HY-B1016R	Trapidil (Standard)	Inhibitor	/	Unkown
HY-B1276A	Metaproterenol	Agonist	/	Unkown
HY-B1486A	Oxprenolol	Antagonist	/	Unkown
HY-B1562	Bopindolol		/	Unkown
HY-12502AR	Efonidipine hydrochloride monoethanolate (Standard)	Inhibitor	/	Unkown
HY-B0010E	Arformoterol maleate	Agonist	/	Unkown
HY-B1470R	Azaperone (Standard)	Antagonist	/	Unkown

Clinical Phase

Bioactive Molecules (61)

Cat. No.	Product Name	Effect	Purity	Phase
HY-15758	3,3'-Diindolylmethane		99.89%	Phase 4
HY-N0378R	D-Mannitol (Standard)		99.96%	Phase 4
HY-12023	GTx-007	Modulator	99.61%	Phase 4
HY-106827	Trimegestone		/	Phase 4
HY-159686	Aclidinium	Agonist	/	Phase 4
HY-10211	Tanespimycin		99.01%	Phase 3
HY-158101	BMS-986365	Degrader	99.92%	Phase 3
HY-13591	Piclidenoson		99.01%	Phase 3
HY-12365	Namodenoson	Agonist	99.56%	Phase 3
HY-50289	Sorbinil	Inhibitor	99.85%	Phase 3
HY-70006	Galeterone		99.87%	Phase 3
HY-15314	Ranirestat	Inhibitor	96.10%	Phase 3
HY-101479	Iclaprim	Inhibitor	98.92%	Phase 3
HY-18967	Caficrestat	Inhibitor	99.74%	Phase 3
HY-70002S	Deutenzalutamide		99.80%	Phase 3
HY-14561	Idazoxan		/	Phase 3
HY-135487	Sibenadet	Agonist	/	Phase 3
HY-105122	Zanoterone	Antagonist	/	Phase 3
HY-111784	Inobrodib	Inhibitor	99.95%	Phase 2
HY-138641	Bavdegalutamide	Inhibitor	99.64%	Phase 2
HY-153342	Luxdegalutamide	Degrader	98.99%	Phase 2
HY-106178	PMX-53	Antagonist	99.95%	Phase 2
HY-101978	Ciforadenant	Antagonist	99.92%	Phase 2
HY-129393	Etrumadenant	Antagonist	99.67%	Phase 2
HY-101980	Imaradenant	Antagonist	99.68%	Phase 2
HY-100186	GSK-2881078	Modulator	99.42%	Phase 2
HY-111151	AR-9281	Inhibitor	99.69%	Phase 2
HY-11027	MK-0773	Inhibitor	99.92%	Phase 2
HY-19687	Zopolrestat	Inhibitor	99.92%	Phase 2
HY-115282A	JNJ-63576253	Antagonist	99.20%	Phase 2
HY-109139	Taminadenant	Antagonist	99.84%	Phase 2
HY-123875A	Ralaniten triacetate	Inhibitor	98.79%	Phase 2
HY-15996	Seviteronel		99.83%	Phase 2
HY-111024	2,2,5,7,8-Pentamethyl-6-Chromanol		99.30%	Phase 2
HY-19436	Solabegron	Agonist	99.89%	Phase 2
HY-106954	Upidosin	Antagonist	99.48%	Phase 2
HY-106303	YT 146	Agonist	99.72%	Phase 2
HY-16055	Silatecan	Inhibitor	96.62%	Phase 2
HY-101555	M 16209	Inhibitor	/	Phase 2
HY-10273	Atecegatran metoxil	Inhibitor	/	Phase 2
HY-106186	GW-493838	Agonist	/	Phase 2
HY-106388	Fadolmidine	Agonist	/	Phase 2
HY-12172	MK-8141	Inhibitor	/	Phase 2
HY-124742	AR-HO47108	Inhibitor	/	Phase 2
HY-14897	Rezatomidine	Agonist	/	Phase 2
HY-16741	Erlosiban	Antagonist	/	Phase 2
HY-16758A	Verosudil hydrochloride	Inhibitor	/	Phase 2
HY-182783	JNJ-10450232	Agonist	/	Phase 2
HY-19885	AR-102	Inhibitor	/	Phase 2
HY-U00371	AR-08	Agonist	/	Phase 2
HY-10547	OSU-03012		99.80%	Phase 1
HY-103169	SCH442416	Antagonist	99.94%	Phase 1
HY-13265	AR-42	Inducer	98.52%	Phase 1
HY-112052	Aminomalonic acid		99.97%	Phase 1
HY-12798C	AR-13503	Inhibitor	98.21%	Phase 1
HY-16079	AZD3514	Inhibitor	99.65%	Phase 1
HY-156751A	GDC-2992	Degrader	99.38%	Phase 1
HY-125639	(rac)-AR-13503	Inhibitor	99.08%	Phase 1
HY-148954	PBF-999	Antagonist	98.89%	Phase 1
HY-177670	Zintevir	Inhibitor	/	Phase 1
HY-157472	ACT-1014-6470	Antagonist	/	Phase 1

Inhibitory Antibodies (4)

Cat. No.	Product Name	Effect	Purity	Phase
HY-P99551	Tosatoxumab		95.00%	Phase 3
HY-P99450	Avdoralimab	Inhibitor	99.25%	Phase 2
HY-P991493	AR-201	Inhibitor	/	Phase 2
HY-P990745	Izastobart	Ligand	99%	Phase 1

Pre-clinical Phase

Bioactive Molecules (747)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-153169	6PPD-Q	Inhibitor	99.77%	Unkown
HY-145388	AU-15330	Degrader	99.89%	Unkown
HY-13248	AR-C155858	Inhibitor	99.62%	Unkown
HY-19532	ZM241385	Antagonist	99.45%	Unkown
HY-W187305	MASM7		99.85%	Unkown
HY-100543	Zenidolol		99.60%	Unkown
HY-135794	11-Ketodihydrotestosterone	Agonist	99.87%	Unkown
HY-101106	AR7	Antagonist	99.38%	Unkown
HY-134923	CA77.1	Inducer	99.92%	Unkown
HY-138161	JR14a	Antagonist	99.77%	Unkown
HY-W093399	Ammonium bicarbonate,AR,99%	Inhibitor	99.0%	Unkown
HY-110136A	PMX 205 Trifluoroacetate	Antagonist	99.50%	Unkown
HY-Y0537	Potassium chloride, AR, 99.5%		99.6%	Unkown
HY-10512	AR-A014418	Inhibitor	99.21%	Unkown
HY-12111	BMS-564929	Agonist	98.28%	Unkown
HY-N0236	Corylin	Inhibitor	99.97%	Unkown
HY-110126	AR-C118925XX	Antagonist	≥99.0%	Unkown
HY-N0790	Lupeol		98.0%	Unkown
HY-131498	Mca-PLGL-Dpa-AR-NH2	Substrate	99.86%	Unkown
HY-N1943	Ailanthone	Inhibitor	99.93%	Unkown
HY-P4931	Mca-KPLGL-Dap(Dnp)-AR-NH2		99.30%	Unkown
HY-101986	BIIE-0246	Antagonist	99.10%	Unkown
HY-W015061	Phenylacetylglycine		99.38%	Unkown
HY-158113	CBPD-409	Degrader	99.38%	Unkown
HY-Y0332B	Potassium dihydrogen phosphate, AR,99.5%	Activator	99.7%	Unkown
HY-N2037	Higenamine		99.31%	Unkown
HY-W011927	4,4'-Sulfonyldiphenol		99.81%	Unkown
HY-110136	PMX 205	Antagonist	99.95%	Unkown
HY-116522	AR420626		98.40%	Unkown
HY-N0166	Gramine		99.80%	Unkown
HY-130492	ARCC-4	Inhibitor	99.88%	Unkown
HY-N0092S2	Inosine-13C5	Agonist	99.90%	Unkown
HY-153918	(R)-SKBG-1	Inhibitor	99.68%	Unkown
HY-121251	BI-167107	Agonist	99.61%	Unkown
HY-176521	AR/BRD4 RIPTAC-1		98.65%	Unkown
HY-13981	Ligandrol		99.93%	Unkown
HY-19334	L755507	Agonist	98.89%	Unkown
HY-Y0261A	Ammonium sulphate,≥99.0%,AR		99.30%	Unkown
HY-149433	BWA-522		98.04%	Unkown
HY-N0819	Raddeanin A		98.68%	Unkown
HY-148141	JPE-1375	Antagonist	99.96%	Unkown
HY-P1345A	TLQP-21 TFA	Agonist	99.90%	Unkown
HY-114936	Piericidin A	Inhibitor	99.83%	Unkown
HY-148771	MTX-23		99.79%	Unkown
HY-173626	EN1441	Degrader	99.67%	Unkown
HY-78055	2-(((3aR,4S,6R,6aS)-6-((5-Amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol		99.76%	Unkown
HY-145479	PROTAC AR-V7 degrader-1	Degrader	98.19%	Unkown
HY-100554	BMY 7378		99.92%	Unkown
HY-15564	AR 231453	Agonist	99.58%	Unkown
HY-161409	SC912		99.13%	Unkown
HY-B0845	Prochloraz		99.85%	Unkown
HY-145237	BM213		99.62%	Unkown
HY-110012	SCH-202676 hydrobromide	Modulator	98.85%	Unkown
HY-116501	VPC-14449	Inhibitor	99.51%	Unkown
HY-30756	tert-Butyl 2,7-diazaspiro[3.5]nonane-2-carboxylate		99.89%	Unkown
HY-W250160	PDRN		90.20%	Unkown
HY-103190	MRS1220	Antagonist	99.52%	Unkown
HY-124292	Honokiol DCA	Inhibitor	98.01%	Unkown
HY-169841	IHCH-7086	Agonist	98.96%	Unkown
HY-173634	Mal((3S,3aR,6S,6aR)-Hexahydrofuro[3,2-b]furan-3,6-diamine-PEG12)-β-Glu-PAB-Exatecan	Inhibitor	99.95%	Unkown
HY-P5506	C5a Receptor agonist, W5Cha	Agonist	99.13%	Unkown
HY-161369	CBPD-268	Degrader	99.23%	Unkown
HY-123012	Lubabegron	Modulator	98.40%	Unkown
HY-150102	EPI-7170	Antagonist	99.86%	Unkown
HY-153152	DPTN dihydrochloride	Antagonist	98.47%	Unkown
HY-100348	EPI-001		99.34%	Unkown
HY-W011927S	4,4'-Sulfonyldiphenol-d8		99.21%	Unkown
HY-N2122	Neoisoliquiritin		99.74%	Unkown
HY-N4089	Quercetin 3-gentiobioside	Inhibitor	99.56%	Unkown
HY-109070	Ralaniten	Antagonist	99.57%	Unkown
HY-117669	VPC-14228	Inhibitor	99.36%	Unkown
HY-N2908	Atraric acid		99.97%	Unkown
HY-145709	Ar-V7-IN-1	Inhibitor	98.02%	Unkown
HY-112256	ACP-105	Modulator	98.92%	Unkown
HY-114402	ARD-69	Degrader	99.61%	Unkown
HY-132292	ARD-2128	Inhibitor	99.17%	Unkown
HY-110028	Leelamine hydrochloride		98.10%	Unkown
HY-70002S1	Enzalutamide-d6	Antagonist	99.85%	Unkown
HY-N2673	5-Heptadecylresorcinol	Activator	99.83%	Unkown
HY-W013249	Boc-piperazine-benzoic acid		97.42%	Unkown
HY-136242	UT-34	Degrader	98.09%	Unkown
HY-102076	0990CL		≥98.0%	Unkown
HY-108250	(R)-Bicalutamide	Antagonist	99.95%	Unkown
HY-112257	S-23	Modulator	99.63%	Unkown
HY-141487	CLP-3094	Inhibitor	99.92%	Unkown
HY-162412	PROTAC AR/AR-V7 degrader-1		99.72%	Unkown
HY-164373	SC428		98.0%	Unkown
HY-170329	PROTAC AR Degrader-8		99.98%	Unkown
HY-N6703	ar-Turmerone	Inducer	99.00%	Unkown
HY-110060	NDT 9513727	Antagonist	99.35%	Unkown
HY-117992	BR103		99.66%	Unkown
HY-160020	ET516	Inhibitor	99.13%	Unkown
HY-B1876	Nicosulfuron		97.27%	Unkown
HY-N0475	Triptophenolide		99.98%	Unkown
HY-19337	Ketodarolutamide	Antagonist	98.72%	Unkown
HY-133020	ARD-266	Inhibitor	99.94%	Unkown
HY-156111	ARD-1676	Degrader	99.36%	Unkown
HY-139644	MIPS521	Agonist	98.21%	Unkown
HY-101300	Cirazoline hydrochloride	Agonist	99.56%	Unkown
HY-103245	Cl-4AS-1	Agonist	99.64%	Unkown
HY-147291	VPC-70063		99.92%	Unkown
HY-18775	N6-(4-Hydroxybenzyl)adenosine		99.84%	Unkown
HY-D1606	BODIPY FL prazosin	Inhibitor	99.71%	Unkown
HY-P10639	C5aR2 agonist P32	Agonist	99.17%	Unkown
HY-16758	Verosudil	Inhibitor	98.22%	Unkown
HY-43962	CS-1-65		99.54%	Unkown
HY-78542	Deshydroxyethoxy ticagrelor	Inhibitor	98.82%	Unkown
HY-B1421	Ractopamine hydrochloride	Agonist	99.2%	Unkown
HY-N5124	Meloside A	Inhibitor	98.72%	Unkown
HY-45219	((3aR,4R,6R,6aR)-6-((E)-4-(Hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate		98.90%	Unkown
HY-Y0261AS1	Ammonium sulphate,≥99.0%,AR-N152		99.30%	Unkown
HY-18776	A2AR-agonist-1	Agonist	99.90%	Unkown
HY-103180	2'-MeCCPA	Agonist	99.80%	Unkown
HY-103183	CV1808	Agonist	≥98.0%	Unkown
HY-112895	UT-155	Antagonist	99.55%	Unkown
HY-120208	MK204	Inhibitor	99.7%	Unkown
HY-130992	Androgen receptor antagonist 1	Antagonist	99.64%	Unkown
HY-147907	Adenosine receptor inhibitor 1	Inhibitor	98.29%	Unkown
HY-149862	ARD-2051	Degrader	98.57%	Unkown
HY-15844	AG-825		98.13%	Unkown
HY-N7045	Isosilybin B		99.32%	Unkown
HY-W077477	IHCH-7113		99.76%	Unkown
HY-I0108	2-(((3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol oxalate		98.0%	Unkown
HY-19319	MI-136		99.04%	Unkown
HY-16985S	Darolutamide-d4	Antagonist	98.58%	Unkown
HY-103162	ANR94	Antagonist	98.91%	Unkown
HY-119993	AR03	Inhibitor	99.1%	Unkown
HY-122917	Danshenol A	Inhibitor	99.67%	Unkown
HY-126076A	VPC-80051		99.77%	Unkown
HY-171978A	LM-189 free base	Agonist	99.70%	Unkown
HY-N0092S	Inosine-2,8-d2	Agonist	99.69%	Unkown
HY-N1731	2′-Hydroxy-5′-methoxyacetophenone	Inhibitor	99.96%	Unkown
HY-W007367	2,6-Dichloropurine		99.81%	Unkown
HY-101393A	CGP 12177 hydrochloride	Modulator	99.69%	Unkown
HY-108235A	Lanicemine dihydrochloride	Antagonist	99.92%	Unkown
HY-117971	BVT173187	Inhibitor	99.97%	Unkown
HY-120006A	(rel)-AR234960	Agonist	98.95%	Unkown
HY-131388	ABM-14		98.10%	Unkown
HY-133045	VHL Ligand 8		98.10%	Unkown
HY-139659	ARD-61		99.57%	Unkown
HY-160777	VNPP433-3β		98.01%	Unkown
HY-163340	GA32	Inhibitor	99.67%	Unkown
HY-B0573S	Propranolol-d7 hydrochloride	Antagonist	98.47%	Unkown
HY-B1866	Linuron	Antagonist	99.88%	Unkown
HY-E70333	Microgranulated pectolytic enzyme		/	Unkown
HY-N0378S2	D-Mannitol-13C6		99.96%	Unkown
HY-N7043	Isosilybin A		99.63%	Unkown
HY-113430	5-n-Heneicosylresorcinol	Inhibitor	98.0%	Unkown
HY-151239	ONT-993	Inhibitor	99.85%	Unkown
HY-120018	VPC-13566	Inhibitor	99.92%	Unkown
HY-12122A	AR-C102222 hydrochloride	Inhibitor	99.83%	Unkown
HY-130845A	AR antagonist 1 hydrochloride	Antagonist	99.53%	Unkown
HY-136596	Apalutamide-COOH		99.76%	Unkown
HY-159639	BAY-2925976	Inhibitor	99.14%	Unkown
HY-17042S1	Cetirizine-d8	Antagonist	96.46%	Unkown
HY-B0846	Dimethomorph	Inhibitor	99.10%	Unkown
HY-N0138S1	Theobromine-d3	Inhibitor	99.78%	Unkown
HY-135794S	11-Ketodihydrotestosterone-d3	Agonist	≥99.90%	Unkown
HY-164552	ZNU-IMB-Z15		99.03%	Unkown
HY-W877989	BWA-522 intermediate-1		99.27%	Unkown
HY-148804	Vemtoberant	Antagonist	98.03%	Unkown
HY-N0378S3	D-Mannitol-2-13C		99.95%	Unkown
HY-B0573BS	Propranolol-d7	Antagonist	≥99.0%	Unkown
HY-103246	TFM-4AS-1		99.96%	Unkown
HY-111809	N6-Ethyladenosine	Agonist	99.90%	Unkown
HY-135483A	AR-R17779 hydrochloride	Agonist	99.0%	Unkown
HY-135732	SK33	Antagonist	99.98%	Unkown
HY-147545	A1AR antagonist 6	Antagonist	98.13%	Unkown
HY-147908	Adenosine receptor inhibitor 2	Inhibitor	99.08%	Unkown
HY-15011	L-372662	Antagonist	99.24%	Unkown
HY-156084	LL-K9-3		99.2%	Unkown
HY-161741	VinclozolinM2-2204	Degrader	98.00%	Unkown
HY-162325	WJ-39		99.60%	Unkown
HY-164807	SARD279	Degrader	96.04%	Unkown
HY-168299	AR ligand-30	Ligand	/	Unkown
HY-169387	YT 6-2-PEG3-C2-NH2	Control	99.50%	Unkown
HY-175231	ST171	Agonist	99.34%	Unkown
HY-175652	AZD9750	Degrader	98.15%	Unkown
HY-B0573S1	Propranolol-d7 (ring-d7)	Antagonist	99.80%	Unkown
HY-B1037S	Salbutamol-d3		98.68%	Unkown
HY-B1562B	Bopindolol malonate		98.30%	Unkown
HY-B1866S	Linuron-d6		99.76%	Unkown
HY-N0378S1	D-Mannitol-13C		99.9%	Unkown
HY-P5123A	Arg-Glu(edans)-Ile-His-Pro-Phe-His-Pro-Phe-His-Leu-Val-Ile-His-Thr-Lys(dabcyl)-Arg TFA	Activator	98.75%	Unkown
HY-Y0261AS	Ammonium sulphate-d8		99.6%	Unkown
HY-Y0827	Barium carbonate,AR,99%		99%	Unkown
HY-76819	Benzyl (3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ylcarbamate		98.47%	Unkown
HY-W017742	Rolapitant Intermediate		98.0%	Unkown
HY-W341547	3,4-Dihydro-6,7-isoquinolinediol	Agonist	98.71%	Unkown
HY-W744625	Olodaterol-d3 hydrochloride		99.9%	Unkown
HY-101039A	AR-M 1000390 hydrochloride	Agonist	98.20%	Unkown
HY-101854	N6-(2-Phenylethyl)adenosine	Agonist	99.41%	Unkown
HY-103203	ST91	Agonist	99.75%	Unkown
HY-123012A	Lubabegron fumarate	Antagonist	98.44%	Unkown
HY-14250	PF-998425	Antagonist	98.63%	Unkown
HY-147100	α1A-AR Degrader 9c	Inhibitor	99.60%	Unkown
HY-151604	Transketolase-IN-3	Inhibitor	98.94%	Unkown
HY-162702	AZ'3137	Degrader	99.90%	Unkown
HY-163940	LX1		99.13%	Unkown
HY-17042S	Cetirizine-d4	Antagonist	99.10%	Unkown
HY-170820	XYD049	Inhibitor	99.46%	Unkown
HY-171978	LM-189	Agonist	96.58%	Unkown
HY-178259	α2AR agonist 2	Antagonist	99.46%	Unkown
HY-179226	AP-7-168	Inhibitor	99.89%	Unkown
HY-184126	JZY3221	Inhibitor	98.01%	Unkown
HY-77734	AR-C133913XX		99.76%	Unkown
HY-B1001A	Todralazine hydrochloride	Inhibitor	99.87%	Unkown
HY-P1640	(Trp63,Trp64)-C3a(63-77)	Agonist	99.23%	Unkown
HY-RS00532	AKR1B1 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-130845	AR antagonist 1	Antagonist	99.03%	Unkown
HY-RS00884	Ar Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS17235	Akr1b1 Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W110146	(3aS,4S,6aR)-Biotin-PEG4-Alkyne		99.93%	Unkown
HY-111848	PROTAC AR Degrader-4	Inhibitor	/	Unkown
HY-111848A	PROTAC AR Degrader-4 TFA	Inhibitor	99.26%	Unkown
HY-184124	JZY3032	Inhibitor	/	Unkown
HY-111372A	(Rac)-Finerenone	Antagonist	99.66%	Unkown
HY-133127	AR453588	Activator	99.84%	Unkown
HY-14249S	Bicalutamide-d4		99.5%	Unkown
HY-B1486S	Oxprenolol-d7 hydrochloride	Antagonist	98.25%	Unkown
HY-101986A	BIIE-0246 hydrochloride	Antagonist	99.33%	Unkown
HY-103177	PSB-10 hydrochloride	Inhibitor	98.70%	Unkown
HY-108449S	Acoltremon-d3		99.58%	Unkown
HY-111145	RD162	Antagonist	99.69%	Unkown
HY-111372S1	Finerenone-d5	Antagonist	99.71%	Unkown
HY-119996A	AR-C141990 hydrochloride	Inhibitor	98.2%	Unkown
HY-123358	AR-H049020XX		/	Unkown
HY-12715S	Yohimbine-13C,d3	Antagonist	99.0%	Unkown
HY-14250A	(Rac)-PF-998425	Antagonist	99.45%	Unkown
HY-14296A	PF-610355 (hydrochloride)	Agonist	/	Unkown
HY-144127	AR antagonist 3	Antagonist	99.96%	Unkown
HY-147261	B026	Inhibitor	/	Unkown
HY-151596	MAO-A/5-HT2AR-IN-1	Inhibitor	99.71%	Unkown
HY-154959A	(9R,12aR)-AZD4747	Control	98.90%	Unkown
HY-16060S	Apalutamide-d4	Antagonist	99.93%	Unkown
HY-16060S1	Apalutamide-d3		/	Unkown
HY-160887	FPT	Agonist	98.06%	Unkown
HY-162620	α2A-AR agonist 1	Agonist	99.92%	Unkown
HY-168201	MJP6412		95.90%	Unkown
HY-171048	GTx-027	Modulator	99.61%	Unkown
HY-173703	β-Glu-PAB(CH2NH2)-Exatecan	Inhibitor	96.60%	Unkown
HY-176068	3-Cl-Pyridine-amide-acrylaldehyde-piperazine		99.30%	Unkown
HY-176521A	AR/BRD4 RIPTAC-1 TFA		99.61%	Unkown
HY-179433	PROTAC AR Degrader-12		98.52%	Unkown
HY-90009D	(6S,12aR)-Tadalafil	Inhibitor	99.48%	Unkown
HY-B0010AS	Formoterol-d3	Agonist	99.60%	Unkown
HY-B1037S3	Salbutamol-d9 acetate		99.48%	Unkown
HY-B1114S	Gliquidone-d6		99.42%	Unkown
HY-D1379	Azophloxine		99.71%	Unkown
HY-N0166R	Gramine (Standard)		98.95%	Unkown
HY-N0378S	D-Mannitol-d8		/	Unkown
HY-N4232	Clematichinenoside AR	Inducer	99.74%	Unkown
HY-N7962	Cornoside	Inhibitor	96.0%	Unkown
HY-N9917	Galloylalbiflorin	Antagonist	95.0%	Unkown
HY-P5213	Vasopressin Dimer (parallel) TFA	Activator	99.55%	Unkown
HY-RS01751	C5AR2 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W004425	DMPX	Antagonist	99.66%	Unkown
HY-W015061S	N-(Phenylacetyl-d5)glycine		≥99.0%	Unkown
HY-W653723	N-Nitrosodicyclohexylamine	Antagonist	99.0%	Unkown
HY-111372S	Finerenone-d3		97.12%	Unkown
HY-121837	β2AR-IN-15	Antagonist	98.84%	Unkown
HY-133086	Hydrodolasetron		98.96%	Unkown
HY-134555	A3AR antagonist 4	Antagonist	99.98%	Unkown
HY-138089	17β-Hydroxy exemestane		98.21%	Unkown
HY-16060S2	Apalutamide-13C,d3	Antagonist	99.90%	Unkown
HY-400766	BWA-522 intermediate-2		99.87%	Unkown
HY-B1037S2	Salbutamol-d9		98.42%	Unkown
HY-RS21501	C3ar1 Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS29512	AP1AR Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W076756	4-Piperidyl N-(2-biphenyl)carbamate	Antagonist	99.97%	Unkown
HY-W157299	2-(Bromomethyl)-1-fluoro-3-methoxybenzene		/	Unkown
HY-Z7733	O-Desmethylcarvedilol	Inhibitor	97.4%	Unkown
HY-115282	JNJ-63576253 free base	Antagonist	/	Unkown
HY-B1470S	Azaperone-d4	Antagonist	95.83%	Unkown
HY-N0092S1	Inosine-13C	Agonist	/	Unkown
HY-101514	β3-AR agonist 1	Agonist	/	Unkown
HY-125839	OP-3633	Antagonist	/	Unkown
HY-133127A	AR453588 hydrochloride	Activator	/	Unkown
HY-148804A	Vemtoberant mesylate	Antagonist	/	Unkown
HY-183667	JNJ-pan-AR	Inhibitor	/	Unkown
HY-N0138S	Theobromine-d6	Inhibitor	98.0%	Unkown
HY-100348R	EPI-001 (Standard)		/	Unkown
HY-101039	AR-M 1000390	Agonist	/	Unkown
HY-101393	CGP 12177	Modulator	/	Unkown
HY-101986C	BIIE-0246 dihydrochloride	Antagonist	/	Unkown
HY-10275A	Atecegatran TFA	Inhibitor	/	Unkown
HY-103203A	ST91 free base	Agonist	/	Unkown
HY-10512S	AR-A014418-d3	Inhibitor	/	Unkown
HY-106388A	Fadolmidine hydrochloride	Agonist	/	Unkown
HY-106684A	Ridazolol hydrochloride	Antagonist	/	Unkown
HY-106769A	(3aR,9aR)-Fluparoxan hydrochloride		/	Unkown
HY-106915	SG-210	Inhibitor	/	Unkown
HY-107018	AR-A 2	Antagonist	/	Unkown
HY-108235AS1	Lanicemine-d5 dihydrochloride	Antagonist	/	Unkown
HY-108633	BYK 49187	Inhibitor	/	Unkown
HY-109139A	Taminadenant mesylate	Antagonist	/	Unkown
HY-110202	MRS5698	Agonist	/	Unkown
HY-111044	(+)-JNJ-37654032	Modulator	/	Unkown
HY-111231	CH4933468	Antagonist	/	Unkown
HY-111372B	(R)-Finerenone	Antagonist	99.70%	Unkown
HY-112567	TRR469	Modulator	/	Unkown
HY-113526	AR-12463		/	Unkown
HY-113701	CH5137291	Antagonist	/	Unkown
HY-113781	Ractopamine	Agonist	/	Unkown
HY-113781S	Ractopamine-d6	Agonist	/	Unkown
HY-115940	Aldose reductase-IN-2	Inhibitor	/	Unkown
HY-115977	Aldose reductase-IN-3	Inhibitor	/	Unkown
HY-116042	FSCPX	Antagonist	99.72%	Unkown
HY-116379	RS-100329	Antagonist	/	Unkown
HY-116982	BMY 7378 free base		/	Unkown
HY-117239	SB-206606	Agonist	/	Unkown
HY-117435	CIDD 0067106	Inhibitor	/	Unkown
HY-117527	L742791	Agonist	/	Unkown
HY-117781	GW-5823	Agonist	/	Unkown
HY-117953	RU 59063	Inhibitor	98.61%	Unkown
HY-118260	Phendioxan		/	Unkown
HY-118678	MRS1186	Antagonist	/	Unkown
HY-119088	Estrogen receptor modulator 12	Modulator	/	Unkown
HY-119170	BMS-779333	Antagonist	/	Unkown
HY-119436	LG-120907	Antagonist	/	Unkown
HY-119806	TMPPAA	Agonist	/	Unkown
HY-119996	AR-C141990	Inhibitor	/	Unkown
HY-120090	MRS1177	Antagonist	/	Unkown
HY-120652	A3AR antagonist 3	Antagonist	/	Unkown
HY-12099	A3AR antagonist 2	Antagonist	/	Unkown
HY-121094	Androgen receptor allosteric antagonist 1	Antagonist	/	Unkown
HY-121588	IMTPPE	Inhibitor	/	Unkown
HY-122048	AR-C67085	Antagonist	/	Unkown
HY-122108	Ilicicolin A	Inducer	/	Unkown
HY-122231	MRS3558	Agonist	/	Unkown
HY-122963	Danshenol B		/	Unkown
HY-123059A	(2S,3S)-Zenidolol hydrochloride	Antagonist	/	Unkown
HY-123163	JNJ-1250132		/	Unkown
HY-123308	VPC13163	Inhibitor	/	Unkown
HY-123310	JNJ-26146900	Antagonist	/	Unkown
HY-124270	Sibenadet hydrochloride	Agonist	/	Unkown
HY-124412	Paynantheine	Agonist	/	Unkown
HY-124585	Y08060	Inhibitor	/	Unkown
HY-125065	MK-4541		/	Unkown
HY-125627	CP-394531	Antagonist	/	Unkown
HY-126464	Estromustine	Modulator	/	Unkown
HY-12798CR	AR-13503 (Standard)	Inhibitor	/	Unkown
HY-12798E	(R)-AR-13503	Control	98.20%	Unkown
HY-128934	Antitumor agent-2		/	Unkown
HY-129761	AR 17048	Activator	/	Unkown
HY-130190	Butopamine	Activator	/	Unkown
HY-133044	Boc-Pip-alkyne-Ph-COOH		/	Unkown
HY-133046	VHL Ligand-Linker Conjugates 17		/	Unkown
HY-133862	SCH-202676		99.46%	Unkown
HY-13613S	Dutasteride-13C6		/	Unkown
HY-13613S2	Dutasteride-13C,15N,d		/	Unkown
HY-136960	β2AR antagonist 1	Antagonist	/	Unkown
HY-139046	MEPB	Modulator	/	Unkown
HY-139104	Thailanstatin D		/	Unkown
HY-139694	hA3AR agonist 1	Agonist	/	Unkown
HY-139970	VPC-13789	Inhibitor	/	Unkown
HY-141865	Adenosine receptor antagonist 1	Antagonist	/	Unkown
HY-14249S1	(R)-Bicalutamide-d5		/	Unkown
HY-142923	AR antagonist 2	Antagonist	/	Unkown
HY-14300AS	Vilanterol-d4 trifenatate	Agonist	/	Unkown
HY-14300D	Vilanterol acetate	Agonist	/	Unkown
HY-143471	WNY0824		/	Unkown
HY-143535	HG122		/	Unkown
HY-144115	A1AR antagonist 1	Antagonist	/	Unkown
HY-144116	A1AR antagonist 2	Antagonist	/	Unkown
HY-144672	A2A receptor antagonist 2	Antagonist	/	Unkown
HY-145308	Heterobivalent ligand-1		/	Unkown
HY-145406	IHCH-3064	Inhibitor	/	Unkown
HY-145480	Silodosin Glucuronide sodium		/	Unkown
HY-145698	UCSF678	Agonist	/	Unkown
HY-145699	UCSF686		/	Unkown
HY-145706	A2A/A1 AR antagonist-1	Antagonist	/	Unkown
HY-145862	5-HT6/5-HT2AR antagonist-1	Agonist	/	Unkown
HY-146026	Androgen receptor antagonist 3	Antagonist	/	Unkown
HY-146027	Androgen receptor antagonist 4	Antagonist	/	Unkown
HY-146397	TD-802	Degrader	/	Unkown
HY-146456	A1AR antagonist 3	Antagonist	/	Unkown
HY-146457	A3AR antagonist 1	Antagonist	/	Unkown
HY-146478	A1/A3 AR antagonist 1	Antagonist	/	Unkown
HY-146479	A1/A3 AR antagonist 2		/	Unkown
HY-146494	Androgen receptor antagonist 5	Antagonist	/	Unkown
HY-146979	hA2A/hCA XII modulator 1		/	Unkown
HY-147541	A2A/A3 AR antagonist-1	Antagonist	/	Unkown
HY-147543	A1AR antagonist 4	Antagonist	/	Unkown
HY-147544	A1AR antagonist 5	Antagonist	/	Unkown
HY-147585	C5aR-IN-1		/	Unkown
HY-147586	C5aR-IN-2		/	Unkown
HY-147587	C5aR-IN-3		/	Unkown
HY-147706	AR524		/	Unkown
HY-147875	Aldose reductase-IN-6	Inhibitor	/	Unkown
HY-148252	ADRA1D receptor antagonist 1 free base	Antagonist	/	Unkown
HY-148300	AR-C66096	Antagonist	/	Unkown
HY-148361	Fluorogen binding modulator-1		/	Unkown
HY-148524	β2AR/M-receptor agonist-1		/	Unkown
HY-148525	PF-4348235		/	Unkown
HY-148526	β2AR/M3-receptor agonist-1	Agonist	/	Unkown
HY-148533	β2AR agonist /M-receptor antagonist-1		/	Unkown
HY-148777	A031	Degrader	/	Unkown
HY-149434	PROTAC AR-NTD degrader 1	Inducer	/	Unkown
HY-149727	β2AR agonist 2	Agonist	/	Unkown
HY-149728	β2AR agonist 3	Agonist	/	Unkown
HY-149914	WCA-814	Degrader	/	Unkown
HY-149916	A2AR-antagonist-1	Antagonist	96.68%	Unkown
HY-150025	(4aS,8aR)-NPD-001		/	Unkown
HY-150812	VHL Ligand 23		/	Unkown
HY-150878	AR ligand-4	Ligand	/	Unkown
HY-151266	AR antagonist 4	Antagonist	/	Unkown
HY-151899	A3AR modulator 1	Agonist	/	Unkown
HY-152524	Androgen receptor antagonist 7	Antagonist	/	Unkown
HY-153157	MRS542		/	Unkown
HY-153333	A1/A3 AR antagonist 3	Antagonist	/	Unkown
HY-153519	WWL0245	Inhibitor	/	Unkown
HY-153718	KI-ARv-03	Inhibitor	/	Unkown
HY-155183	A3AR agonist 1	Agonist	/	Unkown
HY-155184	A3AR agonist 2	Agonist	/	Unkown
HY-155543	Anticancer agent 135	Antagonist	/	Unkown
HY-155666	YXG-158	Degrader	/	Unkown
HY-155772	LUF7690		/	Unkown
HY-156751	(Rac)-GDC-2992	Degrader	/	Unkown
HY-156983	MRS 5980		/	Unkown
HY-157425	5-HT2CR agonist 1	Agonist	/	Unkown
HY-157455	AR antagonist 5		/	Unkown
HY-157796	β2AR agonist 4	Agonist	/	Unkown
HY-158057	A2AR/A2BR antagonist 1	Antagonist	/	Unkown
HY-158179	A3AR agonist 3	Agonist	/	Unkown
HY-158180	A3AR agonist 4	Agonist	/	Unkown
HY-158181	A3AR agonist 5	Agonist	/	Unkown
HY-159096	Apoptosis inducer 21	Inducer	/	Unkown
HY-159739	M17-B15	Inhibitor	/	Unkown
HY-159889	hA3AR agonist 2	Agonist	/	Unkown
HY-159922	AR antagonist 9	Antagonist	/	Unkown
HY-160221	PROTAC AR Degrader-7		/	Unkown
HY-160262	PROTAC AR/BET protein degrader-1	Degrader	/	Unkown
HY-160547	PROTAC AR Degrader-5	Degrader	/	Unkown
HY-16060S3	Apalutamide-d7	Antagonist	/	Unkown
HY-160680	AR antagonist 6	Inhibitor	/	Unkown
HY-160692	AR antagonist 7	Antagonist	/	Unkown
HY-160777A	VNPP433-3β dihydrochloride		/	Unkown
HY-160777B	VNPP433-3β hydrochloride		/	Unkown
HY-161717	MRS5663	Agonist	/	Unkown
HY-161718	MRS8028	Agonist	/	Unkown
HY-161810	MRS8247	Modulator	/	Unkown
HY-161836	α2AR agonist 1	Agonist	/	Unkown
HY-162083	CB2R/5-HT1AR agonist 1	Agonist	/	Unkown
HY-162585	5-HT1AR agonist 1	Agonist	/	Unkown
HY-162659	β2AR ligand 1		/	Unkown
HY-163363	β-AR antagonist 2	Antagonist	/	Unkown
HY-163378	C5aR1 antagonist 1	Antagonist	/	Unkown
HY-163379	C5aR1 antagonist 2	Antagonist	/	Unkown
HY-163485	AR antagonist 8	Inhibitor	/	Unkown
HY-163510	AR/AR-V7-IN-1	Inhibitor	/	Unkown
HY-163632	EGFR-IN-112	Inhibitor	/	Unkown
HY-163641	AR Degrader-1	Degrader	/	Unkown
HY-163813	AR Degrader-2	Degrader	/	Unkown
HY-163978	YGZ-331	Activator	/	Unkown
HY-165509	DU172	Ligand	/	Unkown
HY-167905	ATL444	Antagonist	/	Unkown
HY-168141	Androgen receptor antagonist 11	Antagonist	/	Unkown
HY-168168	(5aS,6R,6aR)-MK-8666		/	Unkown
HY-168344	CACPD2011a-0001278239	Activator	/	Unkown
HY-168697	AR ligand-37	Ligand	/	Unkown
HY-169349	Androgen receptor antagonist 12	Antagonist	/	Unkown
HY-169385	ATC-324	Degrader	/	Unkown
HY-169386	YT 6-2 analog-1	Control	/	Unkown
HY-169388	YT 6-2	Control	98.15%	Unkown
HY-169394	5-HT1AR agonist 2		/	Unkown
HY-169967	AR ligand-31		/	Unkown
HY-169975	tert-Butyl 4-(4-(piperazin-1-ylmethyl)piperidin-1-yl)benzoate		/	Unkown
HY-169976	E3 Ligase Ligand-linker Conjugate 140		/	Unkown
HY-170303	AR ligand-32	Ligand	/	Unkown
HY-170304	E3 ligase Ligand 44		/	Unkown
HY-170305	E3 Ligase Ligand-linker Conjugate 145		/	Unkown
HY-170330	AR ligand-33	Ligand	/	Unkown
HY-17042AS1	Cetirizine-d8 dihydrochloride	Antagonist	99.64%	Unkown
HY-170448	PROTAC AR Degrader-9	Degrader	/	Unkown
HY-170449	E3 ligase Ligand 48		/	Unkown
HY-170450	AR ligand-38	Ligand	/	Unkown
HY-170948	A2AR modulator-1	Modulator	/	Unkown
HY-170951	AR antagonist 10	Antagonist	/	Unkown
HY-171467	MRS7799	Antagonist	/	Unkown
HY-171808	ITRI-90		/	Unkown
HY-171809	AR ligand 42	Ligand	/	Unkown
HY-172612	AR antagonist 13	Antagonist	/	Unkown
HY-172624	AR antagonist 14	Antagonist	/	Unkown
HY-172954	Androgen receptor ligand 1		/	Unkown
HY-172956	E3 Ligase Ligand-linker Conjugate 188		/	Unkown
HY-172995	RS130-180	Agonist	/	Unkown
HY-173044	5-HT1AR/5-HT6R ligand-1		/	Unkown
HY-173045	5-HT5AR/5-HT6R ligand-1	Ligand	/	Unkown
HY-173372	PROTAC AR Degrader-10	Degrader	/	Unkown
HY-173373	AR ligand-39	Ligand	/	Unkown
HY-173409	AR antagonist 11		/	Unkown
HY-173474	ERβ agonist-1		/	Unkown
HY-173498	AR ligand 40	Antagonist	/	Unkown
HY-173559	AR antagonist 12	Antagonist	/	Unkown
HY-173635	Mal((3S,3aR,6S,6aR)-Hexahydrofuro[3,2-b]furan-3,6-diamine-PEG12)-β-Glu-PAB		/	Unkown
HY-173640	ID11916		/	Unkown
HY-174157	AR493	Activator	/	Unkown
HY-174377	PeS-9		/	Unkown
HY-174391	AR antagonist 15	Inducer	/	Unkown
HY-174413	A2AAR antagonist 3	Antagonist	/	Unkown
HY-174466	5-HT2AR ligand 1		/	Unkown
HY-175178	Arrestin-3 modulator-1	Modulator	/	Unkown
HY-175285	5-HT2AR-IN-1	Inhibitor	/	Unkown
HY-175455	LYA914		/	Unkown
HY-175456	AR-DBD ligand-1		/	Unkown
HY-175669	ANO1-IN-5	Inhibitor	/	Unkown
HY-175790	AR/BET ligand-1	Ligand	/	Unkown
HY-175791	Ethyl-Cha-thalidomide-NH2		/	Unkown
HY-175906	AR ligand-45	Ligand	/	Unkown
HY-175937	AR ligand-46	Ligand	/	Unkown
HY-175939	AR-V7 ligand-1	Ligand	/	Unkown
HY-175981	Paclitaxel-bromothiophene		/	Unkown
HY-176060	Platelet aggregation-IN-3	Ligand	/	Unkown
HY-176067	LO-4-25	Degrader	/	Unkown
HY-176128	BWA-6047		/	Unkown
HY-176225	BY13		/	Unkown
HY-17627S1	Avacopan-d4	Inhibitor	/	Unkown
HY-176714	VUF26034	Ligand	/	Unkown
HY-176717	5-HT1AR agonist 3	Agonist	/	Unkown
HY-176863	Di(5-(methylsulfonyl)-1,3,4-oxadiazol-2-yl)-benzene-amide-PEG4-ester-2,3,5,6-F-Ph		/	Unkown
HY-177670A	Zintevir sodium	Inhibitor	/	Unkown
HY-177694	PROTAC AR Degrader-11	Degrader	/	Unkown
HY-178030	CAXII-IN-3		/	Unkown
HY-178148	AR antagonist 17	Antagonist	/	Unkown
HY-178413S	D-Mannitol-d4		/	Unkown
HY-178783	MRS8454	Modulator	/	Unkown
HY-178938	AR Degrader-3		/	Unkown
HY-178998	5-HT7R antagonist 5	Antagonist	/	Unkown
HY-179050	Androgen receptor-IN-7		/	Unkown
HY-179051	PSMA ligand 3	Ligand	/	Unkown
HY-179056	Psa-AR		/	Unkown
HY-179123	ZC9		/	Unkown
HY-179124	Apoptosis inducer 52		/	Unkown
HY-179248	Adenosine receptor antagonist 7		/	Unkown
HY-179274	β2AR agonist 5	Agonist	/	Unkown
HY-179277	MIPS3526	Agonist	/	Unkown
HY-179367	AR-102 free acid		/	Unkown
HY-179442	AR ligand-48		/	Unkown
HY-179605	AR ligand-49	Ligand	/	Unkown
HY-179671	A3AR antagonist 6	Antagonist	/	Unkown
HY-179681	A2A/A3 agonist-1	Agonist	/	Unkown
HY-179713	D2R/D3R/5-HT1AR agonist 1	Agonist	/	Unkown
HY-180409	YM580	Antagonist	/	Unkown
HY-180410	YM-1758735	Antagonist	/	Unkown
HY-180423	IRFI-165	Antagonist	98.0%	Unkown
HY-180553	NSD2-IN-6	Inhibitor	/	Unkown
HY-181427	UT-143	Antagonist	/	Unkown
HY-181727	AR/AR-V7 degrader-1		/	Unkown
HY-181877	IHCH-3185		/	Unkown
HY-181970	XY25026	Inhibitor	/	Unkown
HY-181971	XY25028	Inhibitor	/	Unkown
HY-181977	RPI-GLYT2-82	Inhibitor	/	Unkown
HY-182331	WCF-598		/	Unkown
HY-182432	A3AR antagonist-7	Antagonist	/	Unkown
HY-182687	MRS7469	Agonist	/	Unkown
HY-182714	N 0840	Antagonist	/	Unkown
HY-182722	UT-105	Degrader	/	Unkown
HY-182782	Analgesic agent-4	Ligand	/	Unkown
HY-182809	Androgen receptor degrader-6		/	Unkown
HY-183239	A2AR/A2BR antagonist 2	Antagonist	/	Unkown
HY-183287	Androgen receptor antagonist-14	Antagonist	/	Unkown
HY-183357	GABAAR/5-HT2AR modulator-1		/	Unkown
HY-183414	C5aR antagonist-1	Antagonist	/	Unkown
HY-183710	CDK9-IN-50		/	Unkown
HY-183993	A3AR antagonist-8	Antagonist	/	Unkown
HY-184116	A2AR/EGFR-IN-1		/	Unkown
HY-184195	PROTAC AR Degrader-13		/	Unkown
HY-184680	β2AR agonist 6		/	Unkown
HY-184681	β2AR agonist 7		/	Unkown
HY-184896	XYD113	Inhibitor	/	Unkown
HY-184919	LMP2-IN-1	Inhibitor	/	Unkown
HY-184957	Androgen receptor antagonist 15	Antagonist	/	Unkown
HY-185003	α1A-AR ligand-1	Ligand	/	Unkown
HY-185786	CBP/p300-IN-25		/	Unkown
HY-19337S	Ketodarolutamide-d3	Antagonist	/	Unkown
HY-19337S1	Ketodarolutamide-d6	Antagonist	/	Unkown
HY-19436A	Solabegron hydrochloride	Agonist	/	Unkown
HY-19532S	ZM241385-d7	Antagonist	/	Unkown
HY-19682A	Enciprazine dihydrochloride		/	Unkown
HY-400666	AR ligand-44		/	Unkown
HY-400666A	AR ligand-44 TFA		/	Unkown
HY-403733A	(–)-JJ-450	Antagonist	/	Unkown
HY-403733B	(+)-JJ-450		/	Unkown
HY-403733C	JJ-450	Antagonist	/	Unkown
HY-46286	TTFB	Control	99.83%	Unkown
HY-70006A	Galeterone hydrochloride		/	Unkown
HY-77833	RU 56279	Antagonist	99.68%	Unkown
HY-78542S	Deshydroxyethoxy Ticagrelor-d7		/	Unkown
HY-A0052S	(1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-[(1R)-1-[2-(cyclopropylamino)-2-oxoacetyl]butyl]octahydrocyclopenta[c]pyrrole-1-carboxamide-d4		/	Unkown
HY-B0846S	Dimethomorph-d8		/	Unkown
HY-B1001	Todralazine	Inhibitor	/	Unkown
HY-B1037B	Salbutamol adipate		/	Unkown
HY-B1421S	Ractopamine-d6 hydrochloride		/	Unkown
HY-B1421S1	Ractopamine-d9 hydrochloride		/	Unkown
HY-B1421S3	Ractopamine-d5 hydrochloride		/	Unkown
HY-B1486AS	Oxprenolol-d7	Antagonist	98.05%	Unkown
HY-B1562C	Bopindolol fumarate		/	Unkown
HY-ER013S	Sodium carbonate, AR, 99.8%-13C-1		/	Unkown
HY-N0378AGL	D-Mannitol, M200 (GMP Like)		/	Unkown
HY-N0378BGL	D-Mannitol, M100 (GMP Like)		/	Unkown
HY-N0378S4	D-Mannitol-d2		/	Unkown
HY-N0378S5	D-Mannitol-d1		/	Unkown
HY-N0378S6	D-Mannitol-13C,d2		/	Unkown
HY-N10906	(4R,4aS,5aS,6aR,6bS,7aR)-4-Hydroxy-3,6b-dimethyl-5-methylene-4,4a,5,5a,6,6a,7,7a-octahydrocyclopropa[2,3]indeno[5,6-b]furan-2(6bH)-one		/	Unkown
HY-N11163	(Z)-(1R,3R,4R,4aS,8R,8aR)-3,4,8,8a-Tetramethyl-7-oxo-4-(2-(5-oxo-2,5-dihydrofuran-3-yl)ethyl)decahydronaphthalen-1-yl 2-methylbut-2-enoate		/	Unkown
HY-N15686	Torulene		/	Unkown
HY-N16722	(S)-ar-Turmerol		/	Unkown
HY-N17304	10S,13aR-Antofine N-oxide	Substrate	/	Unkown
HY-N17604	(6aR,11aR)-Edunol		/	Unkown
HY-N3716	Dehydroglyasperin D	Inhibitor	/	Unkown
HY-N6703S	ar-Turmerone-d3	Inducer	/	Unkown
HY-N6883	6-Methoxytricin	Inhibitor	/	Unkown
HY-P11007	β-catenin inhibitory peptoid	Inhibitor	/	Unkown
HY-P11191	AR-23	Inhibitor	/	Unkown
HY-P1129	AR-M1896	Agonist	/	Unkown
HY-P11443	SRC2-2 peptide	Ligand	/	Unkown
HY-P11476	(Z-AR)2Rh110	Substrate	/	Unkown
HY-P11660	β-catenin-IN-10	Inhibitor	/	Unkown
HY-P1345	TLQP-21	Agonist	/	Unkown
HY-P1345B	[DArg10, DAla20] TLQP-21		/	Unkown
HY-P1345C	[DArg10, Aib20] TLQP-21	Antagonist	/	Unkown
HY-P3477	Mca-PLA-Nva-Dap(Dnp)-AR-NH2		/	Unkown
HY-P4931A	Mca-KPLGL-Dap(Dnp)-AR-NH2 TFA		/	Unkown
HY-P5010	(D-Arg8)-Inotocin	Antagonist	/	Unkown
HY-P5123	Arg-Glu(edans)-Ile-His-Pro-Phe-His-Pro-Phe-His-Leu-Val-Ile-His-Thr-Lys(dabcyl)-Arg	Activator	/	Unkown
HY-P5214	Vasopressin Dimer (anti-parallel) TFA	Activator	/	Unkown
HY-R01656	hsa-miR-548ar-3p mimic		/	Unkown
HY-R01656A	hsa-miR-548ar-3p agomir		/	Unkown
HY-R01657	hsa-miR-548ar-5p mimic		/	Unkown
HY-R01657A	hsa-miR-548ar-5p agomir		/	Unkown
HY-RI01656	hsa-miR-548ar-3p inhibitor		/	Unkown
HY-RI01656A	hsa-miR-548ar-3p antagomir		/	Unkown
HY-RI01657	hsa-miR-548ar-5p inhibitor		/	Unkown
HY-RI01657A	hsa-miR-548ar-5p antagomir		/	Unkown
HY-RS00883	AR Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS00885	Ar Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS00892	AREG Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS01744	C3AR1 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS01750	C5AR1 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS03439	Cyp19a1 Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W041652	5-Hydroxypentanoic acid		/	Unkown
HY-W087006	p-Hydroxyphenylacetone	Antagonist	/	Unkown
HY-W095672AS4	((2S,7aR)-2-Fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methanol-d2		98.54%	Unkown
HY-W1003189	E3 ligase Ligand 42		/	Unkown
HY-W134312	Calcium citrate,AR,99%		/	Unkown
HY-W140282	Angiotensin II antipeptide	Inhibitor	/	Unkown
HY-W192276	(±)-Desisopropylpropranolol	Antagonist	/	Unkown
HY-W471937	α1B-AR antagonist 1	Antagonist	/	Unkown
HY-W707640	Salbutamol-d4		/	Unkown
HY-W716464	Prochloraz-d7		/	Unkown
HY-W742404	Bopindolol-d9		/	Unkown
HY-W744741	Lupeol-d3		/	Unkown
HY-W751275	Ractopamine-13C2	Agonist	/	Unkown
HY-W751276	Ractopamine-13C6	Agonist	/	Unkown
HY-W854844B	JP-2-196 hydrochloride	Degrader	/	Unkown
HY-W950003	(Rac)-Finerenone-d5		/	Unkown
HY-W957364	Pomalidomide-C2-Br		/	Unkown
HY-100543R	Zenidolol (Standard)		/	Unkown
HY-10064S1	Ticagrelor-d4	Antagonist	/	Unkown
HY-100661	Cetirizine Impurity D	Antagonist	/	Unkown
HY-10122A	(Rac)-Silodosin	Inhibitor	/	Unkown
HY-10122S	Silodosin-d4	Antagonist	/	Unkown
HY-101479S	Iclaprim-d6	Inhibitor	/	Unkown
HY-101977B	(3aR)-Selitrectinib	Inhibitor	/	Unkown
HY-10275	Atecegatran	Inhibitor	/	Unkown
HY-103163	(±)-5'-Chloro-5'-deoxy-ENBA	Agonist	/	Unkown
HY-106178D	PMX 53 monoacetate		/	Unkown
HY-106684	Ridazolol	Antagonist	/	Unkown
HY-106769B	(3aR,9aR)-Fluparoxan		/	Unkown
HY-111206	β3-AR agonist 3	Agonist	/	Unkown
HY-111273	AR244555	Antagonist	/	Unkown
HY-112006	(S)-ar-Curcumene		/	Unkown
HY-114246	ONC1-13B		/	Unkown
HY-114602	AR-C117977	Inhibitor	/	Unkown
HY-115862	Benzo[c][1,8]naphthyridin-6(5H)-one	Inhibitor	/	Unkown
HY-116065	CUMI-101	Agonist	/	Unkown
HY-116508	MK 319	Inhibitor	/	Unkown
HY-118375	Phenylbutyl isoselenocyanate	Inducer	/	Unkown
HY-118944	L-748328	Antagonist	/	Unkown
HY-12122	AR-C102222	Inhibitor	/	Unkown
HY-122053	Amidephrine hydrochloride	Inhibitor	/	Unkown
HY-122177	MK181	Inhibitor	/	Unkown
HY-124259	I-AB-MECA	Ligand	/	Unkown
HY-125602	MNI-444		/	Unkown
HY-131953	Androgen receptor-IN-3	Inhibitor	/	Unkown
HY-136702	L-97-1	Antagonist	/	Unkown
HY-13715S	(Rac)-Norepinephrine-d3 formate		/	Unkown
HY-139444	AR ligand-51	Ligand	/	Unkown
HY-14300S2	Vilanterol-d12	Agonist	/	Unkown
HY-155467	MRS7935	Modulator	/	Unkown
HY-15746S	(rac)-Dobutamine-d4 hydrochloride	Agonist	/	Unkown
HY-15746S1	(rac)-Dobutamine-d6 hydrochloride	Agonist	/	Unkown
HY-158882	FLAC6		/	Unkown
HY-159929	Antibiotic adjuvant 2	Inhibitor	/	Unkown
HY-159930	Antibiotic adjuvant 3	Inhibitor	/	Unkown
HY-162851	Adenosine receptor agonist 1	Agonist	/	Unkown
HY-164371	(+)-JJ-74-138	Antagonist	/	Unkown
HY-164477	FL442	Modulator	/	Unkown
HY-164621	A3AR antagonist 5	Antagonist	98.17%	Unkown
HY-166478S	O-Desmethyl carvedilol-d5	Inhibitor	/	Unkown
HY-166876S	Nicergoline impurity 18-d4		/	Unkown
HY-166887S	Tiotropium bromide impurity-d3		/	Unkown
HY-166898S	trans Nonachlor-13C10		/	Unkown
HY-166906S	cis-Nonachlor-13C10		/	Unkown
HY-168296	AR ligand-29		/	Unkown
HY-168384	M04		/	Unkown
HY-168547S	AR89-d6	Inhibitor	/	Unkown
HY-169966	Boc-CH2-O-(CH2)4-OTs		/	Unkown
HY-170784	TKL-IN-1	Inhibitor	/	Unkown
HY-172730	2,2,3,3,4,4,5,5,5-Nonafluoro-N-(2-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)ethyl)pentanamide		/	Unkown
HY-172955	E3 ligase Ligand 65		/	Unkown
HY-175457	AR-DBD ligand-Linker Conjugate 1		/	Unkown
HY-176129	AR ligand 41	Ligand	/	Unkown
HY-176759	AR-102 isopropyl ester	Agonist	/	Unkown
HY-180455	AR ligand-50	Ligand	/	Unkown
HY-19346	AR-13324 analog mesylate		98.0%	Unkown
HY-19436S	Solabegron-d8	Agonist	/	Unkown
HY-19506	AR-709	Inhibitor	/	Unkown
HY-19682	Enciprazine		/	Unkown
HY-401056	BWA-522 intermediate-3		/	Unkown
HY-B0845R	Prochloraz (Standard)		/	Unkown
HY-B1276S	Metaproterenol-d7 hemisulfate	Agonist	/	Unkown
HY-B1421S2	Ractopamine-d3 hydrochloride	Agonist	98.30%	Unkown
HY-N0092S4	Inosine-13C3	Agonist	/	Unkown
HY-N0166S	Gramine-d2		/	Unkown
HY-N0819R	Raddeanin A (Standard)	Inducer	/	Unkown
HY-N13308	8-Hydroxy-ar-turmerone		/	Unkown
HY-N6703A	(R)-ar-Turmerone		/	Unkown
HY-N8504	Neoaureothin		/	Unkown
HY-P10639A	C5aR2 agonist P32 acetate	Agonist	/	Unkown
HY-RS17019	Areg Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS18377	C5ar1 Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS19897	Fdxr Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS24857	C5ar1 Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS26398	Fdxr Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS28019	C3ar1 Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W069173	2-Thioadenosine	Ligand	96.73%	Unkown
HY-W093399S	Ammonium bicarbonate-15N	Inhibitor	/	Unkown
HY-W130878	4-Octylphenol	Activator	/	Unkown
HY-W353622	2,5-Dioxopyrrolidin-1-yl 4-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)butanoate		/	Unkown
HY-W654262	10α-Methoxy-9,10-dihydrolysergol-d3		/	Unkown
HY-W702056	DMTr-Biotin-C6-CE phosphoramidite		/	Unkown
HY-W728110	5-MeO-pyr-T	Agonist	/	Unkown
HY-W741999	Metaproterenol-d7-1 hemisulfate	Agonist	/	Unkown
HY-W743954	Nicergoline impurity 11-d3		/	Unkown
HY-U00391	β3-AR agonist 2	Agonist	/	Unkown

Inhibitory Antibodies (7)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-P991748	Anti-Human/Mouse Amphiregulin Antibody (AR37)	Inhibitor	99.544%	Unkown
HY-P990188	Anti-Mouse MHC class II (I-A) Antibody (Y-3P)		98.852%	Unkown
HY-P990324	Anti-AA2AR/Adenosine A2aR Antibody (3F6-9G5)	Inhibitor	≥99.0%	Unkown
HY-P991485	Anti-CD88/C5AR1 Antibody (G2_anti-C5aR)	Inhibitor	/	Unkown
HY-P990186	Anti-Mouse MHC Class II (I-Ak, I-Ar, I-Af, I-As,I-Ag7) Antibody (10-3.6.2)		/	Unkown
HY-P991318	AR20.5	Inhibitor	/	Unkown
HY-P991796	Anti-Mouse C5aR Antibody (20/70)	Inhibitor	/	Unkown

Orthologs Information

Species	Symbol	Source	ID
Homo sapiens	Ar	NCBI	NCBI:367